The Belgian medicine company Janssen-Cilag has has laid off one-fifth of its 100 Hungarian employees. The company, which distributes innovative medicine, justified its decision by saying that social support for innovative medicine has dwindled in Hungary in recent years, forcing the move. The company made HUF 12bn in sales in 2011 and spent HUF 500m on clinical research.
